FDA approves Aducanumab, the first new Alzheimer’s disease treatment in almost two decades and the first to attack the disease process. Learn more here.
- You are here:
- Home »
- Blog »
- Latest News »
- FDA Approves New Alzheimer’s Treatment Drug
FDA Approves New Alzheimer’s Treatment Drug
About the Author Long Island Alzheimer's and Dementia Center
At the Long Island Alzheimer's and Dementia Center, our mission is to improve the quality of life for those living with Alzheimer’s disease and related forms of dementia, and their caregivers. We actively work to achieve this mission through research-based programming for all stages of Alzheimer’s, Caregiver Support Groups, in-home respite solutions, transportation options, and additional services.